We propose that C2, which is easily extractable from C. inscriptus and its biosimilars reviewed in this paper could also be investigated for anticancer properties across a panel of cancer cells as CB1/FAAH1 modulators, so that these unique dual pathways can be explored. The gene discussed is CNR1; the disease is cancer.